Friday, November 13, 2026

Global Economy

25 articles

Powell's Fed Exit in May Meets $1.1T U.S. Tax Cut as Social Security Insolvency Moves to 2032

Powell's Fed Exit in May Meets $1.1T U.S. Tax Cut as Social Security Insolvency Moves to 2032

Federal Reserve Chair Jerome Powell's term ends May 2026 as Congress passes $1.1 trillion in tax cuts that push Social Security insolvency to 2032, seven years ahead of schedule. The fiscal expansion contrasts sharply with restrictive monetary policies in Nigeria and Israel, while South Africa and Greece navigate separate debt pressures.

ViaNews Editorial Team•
Fed Holds Steady: What America's Rate Pause Means for the World Economy

Fed Holds Steady: What America's Rate Pause Means for the World Economy

The US Federal Reserve has signalled an indefinite pause on interest rate cuts, marking a turning point after the aggressive easing cycle of late 2024. With policymakers converging on the view that rates are near neutral, global markets, emerging economies, and central banks from Frankfurt to Tokyo must recalibrate. The repricing of Fed expectations carries consequences far beyond American borders.

ViaNews Editorial Team•
Wall Street's AI Profit Mandate Is Reshaping Corporate Strategy Worldwide

Wall Street's AI Profit Mandate Is Reshaping Corporate Strategy Worldwide

Institutional investors are driving a global reallocation of capital as AI-driven productivity gains move from theory to measurable earnings. The shift is rotating money away from first-generation semiconductor winners toward companies owning the operational AI layer — with implications for corporate strategy from New York to Tokyo, Frankfurt to Singapore. Monetary policy uncertainty, particularly in the United States, adds a consequential overlay for international investors navigating this tran

ViaNews Editorial Team•
The Global K-Shape: How the Profit-Labor Divide Is Reshaping Markets From Wall Street to the World

The Global K-Shape: How the Profit-Labor Divide Is Reshaping Markets From Wall Street to the World

A structural split between surging corporate profits and stagnant real wages — first mapped in the U.S. — is now a defining feature of advanced economies worldwide. Bank of America's analysis warns that the widening K-shaped recovery poses systemic risks not just to American equity valuations, but to the consumer-driven growth models underpinning markets from Frankfurt to Tokyo. The divergence is forcing investors globally to rethink how broad-based any economic recovery truly is.

ViaNews Editorial Team•
The Dollar Nobody Controls: How Tether's USDT Is Filling the Void Left by Failed Currencies Worldwide

The Dollar Nobody Controls: How Tether's USDT Is Filling the Void Left by Failed Currencies Worldwide

In economies from Argentina to Nigeria to Vietnam, where local currencies erode faster than wages can adjust, Tether's USDT stablecoin is quietly becoming the de facto dollar for millions who have never held a bank account. With $20 billion in recent redemptions processed without breaking its peg, Tether is making a credibility argument that goes beyond crypto — it is positioning itself as monetary infrastructure for the Global South. The company's pivot toward law enforcement cooperation and Tr

ViaNews Editorial Team•
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Late-2026 Biotech Catalyst Season: FDA Decisions and Pivotal Readouts Converge Across Oncology, Hepatology and Cardiometabolic
Mid-November 2026 is dense with scheduled biotech catalysts. The ivonescimab BLA PDUFA date is 2026-11-14, the lorundrostat PDUFA date is 2026-12-22, and Phase 3 ECLIPSE hepatitis delta data are due in Q1 2027. Alongside these, siRNA and antibody programs (plozasiran, elebsiran/tobevibart, ianalumab, nipocalimab) reported or presented data at AHA, AASLD, ACR and ASH, while Oryzon advanced iadademstat in AML with Spanish trial authorizations and a planned ALICE-3 Phase III. Late-stage data and regulatory milestones are driving the sentiment. A planned delisting (EGM 2026-11-19, application 2027-01-25) is a separate corporate-structure event with no clear link to the rest.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,995
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,995 facts checked against source5,577 source documents archived
Query this data → isubstrate.com